GlaxoSmithKline PLC ADR Cash Flow-to-Debt Ratio
GlaxoSmithKline PLC ADR cash flow-to-debt ratio. GlaxoSmithKline PLC ADR (GSK) has a Cash Flow-to-Debt Ratio of 0.06x as of June 2026, meaning its operating cash flow of $2.54 Billion could theoretically repay 0% of its total liabilities ($44.29 Billion) in one year. Check GSK cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of GlaxoSmithKline PLC ADR (1990–2025)
Cash flow-to-debt ratio of GlaxoSmithKline PLC ADR from 1990 to 2025. Historical debt coverage capacity for GlaxoSmithKline PLC ADR across 36 annual periods. Check GlaxoSmithKline PLC ADR total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
GlaxoSmithKline PLC ADR Cash Flow-to-Debt Ratio by Year (1990–2025)
GlaxoSmithKline PLC ADR cash flow-to-debt ratio by year from 1990 to 2025. Year-by-year debt coverage analysis for GlaxoSmithKline PLC ADR. For the full cash flow conversion analysis, see GSK operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | $7.14 Billion | $45.02 Billion | ▲ +12.3% |
| 2024 | 0.14x | $6.55 Billion | $46.38 Billion | ▲ +5.5% |
| 2023 | 0.13x | $7.89 Billion | $58.91 Billion | ▼ -9.4% |
| 2022 | 0.15x | $7.40 Billion | $50.05 Billion | ▲ +45.5% |
| 2021 | 0.10x | $7.95 Billion | $78.23 Billion | ▼ -1.9% |
| 2020 | 0.10x | $8.44 Billion | $81.50 Billion | ▲ +4.9% |
| 2019 | 0.10x | $8.02 Billion | $81.25 Billion | ▼ -36.2% |
| 2018 | 0.15x | $8.42 Billion | $54.39 Billion | ▲ +18.4% |
| 2017 | 0.13x | $6.92 Billion | $52.89 Billion | ▲ +8.9% |
| 2016 | 0.12x | $6.50 Billion | $54.12 Billion | ▲ +108.3% |
| 2015 | 0.06x | $2.57 Billion | $44.57 Billion | ▼ -60.2% |
| 2014 | 0.14x | $5.18 Billion | $35.72 Billion | ▼ -31.2% |
| 2013 | 0.21x | $7.22 Billion | $34.27 Billion | ▲ +67.3% |
| 2012 | 0.13x | $4.38 Billion | $34.73 Billion | ▼ -35.0% |
| 2011 | 0.19x | $6.25 Billion | $32.25 Billion | ▼ -7.9% |
| 2010 | 0.21x | $6.80 Billion | $32.31 Billion | ▼ -13.8% |
| 2009 | 0.24x | $7.84 Billion | $32.12 Billion | ▲ +3.8% |
| 2008 | 0.24x | $7.31 Billion | $31.07 Billion | ▼ -19.5% |
| 2007 | 0.29x | $6.17 Billion | $21.09 Billion | ▲ +14.0% |
| 2006 | 0.26x | $4.08 Billion | $15.90 Billion | ▼ -18.8% |
| 2005 | 0.32x | $6.20 Billion | $19.63 Billion | ▲ +8.7% |
| 2004 | 0.29x | $4.94 Billion | $17.01 Billion | ▼ -7.2% |
| 2003 | 0.31x | $4.85 Billion | $15.49 Billion | ▲ +52.9% |
| 2002 | 0.20x | $3.06 Billion | $14.94 Billion | ▼ -39.7% |
| 2001 | 0.34x | $4.61 Billion | $13.57 Billion | ▲ +131.7% |
| 2000 | 0.15x | $1.85 Billion | $12.63 Billion | ▲ +107.9% |
| 1999 | 0.07x | $510.00 Million | $7.23 Billion | ▲ +13.1% |
| 1998 | 0.06x | $410.00 Million | $6.58 Billion | ▼ -33.6% |
| 1997 | 0.09x | $615.00 Million | $6.55 Billion | ▼ -22.0% |
| 1996 | 0.12x | $849.00 Million | $7.05 Billion | ▼ -19.9% |
| 1995 | 0.15x | $1.25 Billion | $8.32 Billion | ▼ -53.7% |
| 1994 | 0.33x | $2.45 Billion | $7.53 Billion | ▼ -15.4% |
| 1993 | 0.38x | $1.05 Billion | $2.74 Billion | ▲ +16.2% |
| 1992 | 0.33x | $927.00 Million | $2.80 Billion | ▲ +2.9% |
| 1991 | 0.32x | $657.00 Million | $2.04 Billion | ▲ +28.7% |
| 1990 | 0.25x | $615.00 Million | $2.46 Billion | — |